CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma
Hideki Iwamoto, Shigeo Shimose, Takashi Niizeki, Hironori Koga, Takuji Torimura,
Clin Mol Hepatol. 2022;28(3):575-579.   Published online 2022 April 21    DOI: https://doi.org/10.3350/cmh.2022.0047

Excel Download

Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma
Clinical and Molecular Hepatology. 2022;28(3):575-579   Crossref logo
Link1 Link2 Link3

Changing the Treatment Paradigm for Hepatocellular Carcinoma Using Atezolizumab plus Bevacizumab Combination Therapy
Cancers. 2021;13(21):5475   Crossref logo
Link1

Perfusion Change of Hepatocellular Carcinoma during Atezolizumab plus Bevacizumab Treatment: A Pilot Study
. 2022;   Crossref logo
Link1 Link2

Atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma – Authors' replys
The Lancet Oncology. 2020;21(9):e413   Crossref logo
Link1 Link2

Sequential Therapy for Hepatocellular Carcinoma after Failure of Atezolizumab plus Bevacizumab Combination Therapy
Liver Cancer. 2021;10(2):85-93   Crossref logo
Link1 Link2

A New Era in Systemic Therapy for Hepatocellular Carcinoma: Atezolizumab plus Bevacizumab Combination Therapy
Liver Cancer. 2020;9(2):119-137   Crossref logo
Link1 Link2

Atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma
The Lancet Oncology. 2020;21(9):e412   Crossref logo
Link1 Link2

Bayesian Analysis Supports Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Liver Cancer. 2021;11(2):180-181   Crossref logo
Link1 Link2

Case report: Pseudoglandular hepatocellular carcinoma: Discrepancy between CT and MR findings
Clinical Radiology. 1996;51(5):379-381   Crossref logo
Link1 Link2

The Prognostic Value of Baseline Clinical and Radiologic Imaging Features in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab
Journal of Hepatocellular Carcinoma. 2022;Volume 9:913-927   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.